Gursoy P, Tatli AM, Erdem D, Goker E, et al. Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study. J Cancer Res Clin Oncol 2022 Apr 5. pii: 10.1007/s00432-022-03984.
PMID: 35381885